HELP Committee Schedules Compounding Pharmacy Hearing

The May 9 hearing follows introduction of a bill by four members of the committee to clarify state and federal authorities' oversight responsibilities.

The U.S. Senate's Health, Education, Labor and Pensions Committee has scheduled a hearing May 9 about improving oversight of compounding pharmacies such as the New England Compounding Center, some of whose products are involved in a multi-state outbreak of fungal meningitis. It began in September 2012 when NECC recalled three lots of preservative-free methylprednisolone acetate associated with the outbreak.

The committee's chairman, Sen. Tom Harkin, D-Iowa, introduced a bill April 26 along with Ranking Member Sen. Lamar Alexander, R-Tenn., Sen. Al Franken, D-Minn., and Sen. Pat Roberts, R-Kan., to clarify the compounding oversight responsibilities of state and federal authorities. The bill would amend the Federal Food, Drug, and Cosmetic Act with respect to compounding drugs. It distinguishes between traditional compounding, which would continue to be regulated primarily by state pharmacy boards, and compounding manufacturers that make sterile products without, or in advance of, a prescription and sell them across state lines. These would be regulated by the Food and Drug Administration.

Harkin called the bill "a significant step forward in protecting the public from unsafe compounded products. By clarifying FDA authority over high-risk compounding practices, this bill will enhance protections for patients taking compounded drugs and help prevent crises like last year's tragic meningitis outbreak," he added.

"When drugs are prescribed to make a patient healthier -- and in many cases, save a life -- that patient should know their prescription is exactly what the doctor ordered," Franken said. "We've seen far too many deaths in this country because some pharmacies have acted more like drug manufacturers, without following rigorous safety rules. This legislation will keep Minnesotans safe by ensuring that drug manufacturers have appropriate oversight and that responsible pharmacies don't see any unnecessary restrictions."

The committee's hearing is scheduled to include five witnesses:

  • Dr. Janet Woodcock, director, Center for Drug Evaluation and Research, Food and Drug Administration
  • Carmen S. Catizone, executive director, National Association of Boards of Pharmacy, Mount Prospect, Ill.
  • Allan Coukell, director, Medical Programs, The Pew Charitable Trusts, Washington, D.C.
  • David G. Miller, executive vice president and CEO, International Academy of Compounding Pharmacy, Missouri City, Texas
  • Dr. Kasey K. Thompson, vice president, Office of Policy, Planning and Communications, American Society of Health-System Pharmacists, Bethesda, Md.

Download Center

  • Safety Metrics Guide

    Is your company leveraging its safety data and analytics to maintain a safe workplace? With so much data available, where do you start? This downloadable guide will give you insight on helpful key performance indicators (KPIs) you should track for your safety program.

  • Job Hazard Analysis Guide

    This guide includes details on how to conduct a thorough Job Hazard Analysis, and it's based directly on an OSHA publication for conducting JHAs. Learn how to identify potential hazards associated with each task of a job and set controls to mitigate hazard risks.

  • A Guide to Practicing “New Safety”

    Learn from safety professionals from around the world as they share their perspectives on various “new views” of safety, including Safety Differently, Safety-II, No Safety, Human and Organizational Performance (HOP), Resilience Engineering, and more in this helpful guide.

  • Lone Worker Safety Guide

    As organizations digitalize and remote operations become more commonplace, the number of lone workers is on the rise. These employees are at increased risk for unaddressed workplace accidents or emergencies. This guide was created to help employers better understand common lone worker risks and solutions for lone worker risk mitigation and incident prevention.

  • EHS Software Buyer's Guide

    Learn the keys to staying organized, staying sharp, and staying one step ahead on all things safety. This buyer’s guide is designed for you to use in your search for the safety management solution that best suits your company’s needs.

  • Vector Solutions

Featured Whitepaper

OH&S Digital Edition

  • OHS Magazine Digital Edition - July August 2022

    July / August 2022

    Featuring:

    • CONFINED SPACES
      Specific PPE is Needed for Entry and Exit
    • HAZARD COMMUNICATION
      Three Quick Steps to Better HazCom Training
    • GAS DETECTION
      Building a Chemical Emergency Toolkit
    • RESPIRATORY PROTECTION
      The Last Line of Defense
    View This Issue